CNPY2 and α‐SMA expression were notably upregulated in IPF lung fibroblast and reduced after hsa‐miR‐30a‐3p treatment (Figure S5A, Supporting Information). Here, CNPY2 is linked to idiopathic pulmonary fibrosis.